Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Berlin - Delayed Quote EUR

Agios Pharmaceuticals Inc (8AP.BE)

Compare
23.20
-2.00
(-7.94%)
At close: April 4 at 9:52:08 PM GMT+2
Loading Chart for 8AP.BE
  • Previous Close 25.20
  • Open 24.80
  • Bid 22.80 x --
  • Ask 32.00 x --
  • Day's Range 23.20 - 25.00
  • 52 Week Range 23.20 - 58.50
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Apr 30, 2025 - May 5, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 8AP.BE

View More

Performance Overview: 8AP.BE

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

8AP.BE
26.58%
S&P 500 (^GSPC)
13.73%

1-Year Return

8AP.BE
10.77%
S&P 500 (^GSPC)
1.42%

3-Year Return

8AP.BE
18.88%
S&P 500 (^GSPC)
10.72%

5-Year Return

8AP.BE
16.55%
S&P 500 (^GSPC)
103.89%

Compare To: 8AP.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8AP.BE

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    1.33B

  • Enterprise Value

    575.22M

  • Trailing P/E

    2.20

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    40.64

  • Price/Book (mrq)

    0.95

  • Enterprise Value/Revenue

    17.40

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 8AP.BE

View More

Company Insights: 8AP.BE

Research Reports: 8AP.BE

View More